Pitfalls in comparing breast cancer survival of elderly patients between hospitals without comorbidity or cause of death data

Annals of Oncology

Volumn 21, Issue 10, 2010, Pages 2120-2120

  Wear, H ^a   Pittam, M ^a   Ravichandran, D ^a  

^a LUTON AND DUNSTABLE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

AGED; ASPIRATION BIOPSY; BREAST CANCER; BREAST SURGERY; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURVIVAL; COMORBIDITY; ELDERLY CARE; FEMALE; HUMAN; LETTER; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PRIORITY JOURNAL; SURVIVAL TIME;

EID: 77957124193     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdq459     Document Type: Letter

References (3)

1. Wishart GC, Greenberg DC, Chou P et al. Treatment and survival in breast cancer in the Eastern Region of England. Ann Oncol 2010; 21(2): 291-296.
2. Charlson ME, Pompei P, Ales K, MacKenzie R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40(5): 373-383.
3. Yancik R, Wesley MN, Ries LA et al. Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older. JAMA 2001; 285(7): 885-892.